U.S. flag

An official website of the United States government, Department of Justice.

NCJRS Virtual Library

The Virtual Library houses over 235,000 criminal justice resources, including all known OJP works.
Click here to search the NCJRS Virtual Library

Pergolide Mesylate: Adverse Events Occurring in the Treatment of Cocaine Dependence

NCJ Number
166331
Journal
American Journal on Addictions Volume: 6 Issue: 2 Dated: (Spring 1997) Pages: 117-123
Author(s)
R Malcolm; J W Moore; D K Kajdasz; C E Cochrane
Date Published
1997
Length
7 pages
Annotation
The use of pergolide mesylate for persons dependent on cocaine was studied in a study of 235 outpatients.
Abstract
The research used a placebo-controlled, double-blind, dose-response method. Seventy-six percent of the sample consisted of males between ages 20 and 48 years; the other 24 percent consisted of females between ages 22 and 48. Eight of the 235 participants noted adverse events, which required breaking of the blind condition of the study. The adverse events occurred at or within 7 days of receiving the first doses of medication. The events included side effects (four cardiovascular and one psychiatric); drug-drug interactions (one); and clinical exclusions (two pregnancies). Two anecdotes of illicit abuse were reported. Findings indicated that although efficacy is not established, pergolide appears to be safe in the early treatment of cocaine dependence except where relative contraindications exist. Case summaries and 17 references (Author abstract modified)

Grant Number(s)
RO1-DA08355
Sponsoring Agency
National Institute on Drug Abuse
Address

National Institutes of Health, 6001 Executive Boulevard, Room 5213, Bethesda, MD 20892-9561, United States

Publication Format
Article
Publication Type
Survey
Language
English
Country
United States of America
Note
DCC

Downloads

No download available